Amarin Corporation PLC Average Common Equity

Average Common Equity of AMRN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Average Common Equity growth rates and interactive chart.


Highlights and Quick Summary

  • Average Common Equity for the quarter ending September 30, 2022 was $615 Million (a 0.4% increase compared to previous quarter)
  • Year-over-year quarterly Average Common Equity decreased by -4.97%
  • Annual Average Common Equity for 2021 was $648 Million (a 6.67% increase from previous year)
  • Annual Average Common Equity for 2020 was $607 Million (a 69.55% increase from previous year)
  • Annual Average Common Equity for 2019 was $358 Million (a 1646.34% increase from previous year)
Visit stockrow.com/AMRN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Average Common Equity of Amarin Corporation PLC

Most recent Average Common Equityof AMRN including historical data for past 10 years.

Interactive Chart of Average Common Equity of Amarin Corporation PLC

Amarin Corporation PLC Average Common Equity for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $615.16 $612.68 $637.86
2021 $647.3 $622.16 $620.46 $599.27 $647.5
2020 $606.96 $587.93 $361.42 $341.47 $607.0
2019 $358.45 $249.68 $28.09 $39.0 $358.0
2018 $20.51 $-72.57 $-67.09 $-47.08 $20.5
2017 $-61.44 $-39.83 $-125.95 $-116.82 $-61.21
2016 $-92.67 $-72.32 $-150.75 $-134.25 $-92.67
2015 $-120.18 $-102.35 $-81.35 $-72.8 $-120.18
2014 $-61.15 $-43.47 $-72.16 $-58.84 $-61.15
2013 $-18.93 $-8.83 $-44.51 $-62.25 $-18.93
2012 $-4.98 $-15.15 $-74.7 $-55.43 $-4.98
2011 $-104.16 $-104.16

Business Profile of Amarin Corporation PLC

Sector: Healthcare
Industry: Biotechnology